Family-focused Treatment for Childhood-onset Depressive Disorders: Results of an Open Trial

Department of Psychology, Boston University, MA 02215, USA.
Clinical Child Psychology and Psychiatry (Impact Factor: 1.03). 08/2007; 12(3):403-20. DOI: 10.1177/1359104507078474
Source: PubMed


Study objectives were to develop a treatment manual for a family-focused intervention for depressed school-aged children, evaluate its feasibility and acceptability, and complete an initial open trial to examine treatment effects. Nine young people meeting criteria for depression (major depressive disorder, dysthymic disorder, or depression not otherwise specified), completed a 12-week family intervention, and were assessed immediately and at 9 months following treatment completion. The intervention presented an interpersonal model of how depressive symptoms are maintained, and emphasized developing family strategies for altering interpersonal processes, supporting recovery and enhancing resilience. At posttreatment 66% of the young people had recovered from their depressive episodes; by 9 months posttreatment 77% had recovered. Significant improvements in global functioning were noted. There were no relapses in the follow-up period and no instances of suicidal behavior during the intervention or follow-up. Mothers' and fathers' Child Behavior Checklist reports and children's self reports indicated significant symptom reductions. Exploratory analyses suggest particular benefit for young people with parents high in criticism. The family-focused intervention for childhood-onset depression demonstrated gains similar to those seen with empirically supported treatments for depressed adolescents and superior to those seen in naturalistic studies of depression outcomes. This favorable risk/benefit profile supports the value of a randomized controlled trial.

Download full-text


Available from: Jason M Fogler,
  • [Show abstract] [Hide abstract]
    ABSTRACT: First Page of the Article
    Geoscience and Remote Sensing Symposium, 1989. IGARSS'89. 12th Canadian Symposium on Remote Sensing., 1989 International; 08/1989
  • Young ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Collins and Dozois (2008) review the depression prevention literature to identify active components of existing programs with the goal of advancing the field. This commentary highlights some of the issues raised by Collins and Dozois as well as other areas that are crucial to the advancement of depression prevention. These include (a) reframing the debate about core intervention components, (b) designing studies with the goal of identifying putative mechanisms, (c) developing novel preventive interventions, (d) empirically studying the involvement of parents in prevention programs, and (e) investigating the effectiveness of preventive interventions when delivered by real-world clinicians.
    Clinical Psychology Science and Practice 12/2008; DOI:10.1111/j.1468-2850.2008.00144.x · 2.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is a well-developed literature on depression in adults, including risk factors, phenomenology, correlates, course, and biological substrates (Kessler et al., 2003). Examination of both psychopharmacologic and psychosocial treatments is extensive (de Maat, Dekker, Schoevers&de Jonghe, 2007), and treatment guidelines have been developed to direct clinicians' interventions (American Psychiatric Association, 2006). However, examination of depression in youth has commenced much more recently, and the research literature to guide treatment is less well-developed. The last 25 years have seen a surge in our understanding of the phenomenology, course, correlates and etiology of youth depression. Despite the many questions that remain, the field has moved forward in the development of efficacious treatment strategies. Recent data support the use of selective serotonin reuptake inhibitors (SSRIs) in the treatment of youth depression (Emslie, et al. 1997; 2002; Keller et al., 2001; Wagner et al., 2003, 2004) but do not suggest efficacy for tricyclic antidepressants (Keller et al., 2001). Given the rates of adverse events in clinical trials with youth (Cheung, Emslie&Mayes, 2005), their limited efficacy (Hamrin&Scahill, 2005), and recent concerns about the potential for increased risk of self-harm associated with SSRIs in youth (United States Food and Drug Administration, 2004), there is a strong need for the development of effective psychosocial treatments as treatment alternatives and supplements to medication in the comprehensive treatment of depressed youth.
Show more